enGene Therapeutics Inc. (ENGN)
Market Closed
17 Jul, 20:00
NASDAQ (CM) NASDAQ (CM) Primary 
XFRA $
1. 82
-0.1
-5.2083%
$
97.01M Market Cap
- P/E Ratio
- Div Yield
798,900 Volume
- Eps
$ 1.92
Previous Close 
Want to track ENGN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
ENGN Earnings Reports FAQ
What is the earnings per share (EPS) for ENGN?
EPS data for ENGN is currently not available, as enGene Therapeutics Inc has not reported recent earnings.
What is the company's earnings growth rate?
enGene Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
enGene Therapeutics Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for enGene Therapeutics Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for ENGN at this time, as enGene Therapeutics Inc has no recent EPS data to calculate it.
